Small extracellular
vesicles (sEVs) are promising for cell-based
cardiac repair after myocardial infarction. These sEVs encapsulate
potent cargo, including microRNAs (miRs), within a bilayer membrane
that aids sEV uptake when administered to cells. However, despite
their efficacy, sEV therapies are limited by inconsistencies in the
sEV release from parent cells and variability in cargo encapsulation.
Synthetic sEV mimics with artificial bilayer membranes allow for cargo
control but suffer poor stability and rapid clearance when administered in vivo. Here, we developed an sEV-like vehicle (ELV) using
an electroporation technique, building upon our previously published
work, and investigated the potency of delivering electroporated ELVs
with pro-angiogenic miR-126 both in vitro and in vivo to a rat model of ischemia–reperfusion. We
show that electroporated miR-126+ ELVs improve tube formation parameters
when administered to 2D cultures of cardiac endothelial cells and
improve both echocardiographic and histological parameters when delivered
to a rat left ventricle after ischemia reperfusion injury. This work
emphasizes the value of using electroporated ELVs as vehicles for
delivery of select miR cargo for cardiac repair.